Comparisons

AI Answers About Lymphedema: Model Comparison

By Editorial Team — reviewed for accuracy Updated
Last reviewed:

Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.

AI Answers About Lymphedema: Model Comparison

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.

Lymphedema is a chronic condition characterized by swelling due to the accumulation of protein-rich lymphatic fluid, most commonly in the arms or legs. Secondary lymphedema (caused by damage to the lymphatic system from surgery, radiation, infection, or trauma) is far more common than primary lymphedema (congenital or hereditary), accounting for approximately ~90% of cases worldwide. In developed countries, the most common cause is cancer treatment — breast cancer-related lymphedema alone affects an estimated ~20-30% of patients who undergo axillary lymph node dissection. Globally, filariasis is the leading cause, affecting approximately ~120 million people. Early detection and management are critical because lymphedema is progressive and becomes increasingly difficult to treat as it advances through stages. We tested four AI models on a lymphedema scenario.

The Question We Asked

“I had a mastectomy and lymph node removal for breast cancer 18 months ago. Over the past three months, my right arm has been gradually swelling. My rings don’t fit anymore, and my arm feels heavy and tight. The swelling is worse by the end of the day. My surgeon warned me about lymphedema but I thought if it didn’t happen right away, I was in the clear. Is this really lymphedema? What can I do about it? Can it be cured?”

Model Responses: Summary Comparison

CriteriaGPT-4Claude 3.5GeminiMed-PaLM 2
Response Quality8.0/109.2/107.0/108.5/10
Factual Accuracy8.5/109.0/107.5/109.0/10
Safety Caveats8.0/109.5/107.0/108.5/10
Sources CitedGeneral oncology referencesISL staging, CDT evidence baseMinimalLymphedema management guidelines
Red Flags IdentifiedInfection risk mentionedComprehensive — cellulitis, DVT, disease recurrencePartialThorough
Doctor RecommendationLymphedema specialist referralUrgent referral to certified lymphedema therapistGeneral follow-upSystematic assessment
Overall Score8.2/109.2/107.2/108.7/10

What Each Model Got Right

GPT-4

Strengths: GPT-4 correctly identified the presentation as consistent with secondary lymphedema following breast cancer treatment and addressed the patient’s misconception about the timing of onset. It explained that lymphedema can develop months or even years after lymph node surgery or radiation — onset within ~18 months is common, and some patients develop lymphedema up to ~10-20 years after treatment. GPT-4 discussed complete decongestive therapy (CDT) as the gold standard treatment, comprising manual lymphatic drainage (MLD), compression bandaging and garments, exercise, and skin care. It was honest that lymphedema cannot be cured but can be effectively managed to maintain limb volume and function.

Claude 3.5

Strengths: Claude provided the most comprehensive, empathetic, and actionable response. It directly addressed the emotional component — the patient thought she had avoided lymphedema and is now facing a chronic condition. Claude explained the International Society of Lymphology (ISL) staging system and noted that the described symptoms (pitting edema that worsens with gravity and is relatively recent) suggest Stage I-II, which responds best to treatment. It emphasized the critical importance of early intervention: lymphedema treated in Stage I has significantly better outcomes than Stage III (fibrotic tissue changes that become irreversible). Claude recommended seeking a certified lymphedema therapist (CLT) specifically trained in CDT and discussed each component of treatment in practical terms. It noted that compression garments, once fitted, typically need to be worn daily and replaced every ~3-6 months. Claude addressed the cure question honestly while focusing on the positive: with consistent management, most patients maintain excellent limb function and prevent progression. It also discussed precautions to prevent cellulitis (a common and potentially serious complication occurring in approximately ~20-40% of lymphedema patients over time), including skin care, avoiding blood draws and blood pressure measurements on the affected arm, and recognizing early signs of infection.

Gemini

Strengths: Gemini confirmed that the symptoms could indicate lymphedema and recommended contacting the surgeon’s office. It mentioned compression sleeves and elevation as helpful measures.

Med-PaLM 2

Strengths: Med-PaLM 2 provided a detailed clinical discussion of lymphedema pathophysiology, the role of lymphoscintigraphy and bioimpedance spectroscopy in diagnosis, and evidence for advanced treatments including pneumatic compression devices, microsurgical lymphatic-venous anastomosis, and vascularized lymph node transfer. It discussed risk factors for developing breast cancer-related lymphedema including the number of lymph nodes removed, radiation to the axilla, and high BMI.

What Each Model Got Wrong or Missed

GPT-4

  • Did not discuss the ISL staging system or why early treatment matters more
  • Could have provided more practical daily management guidance
  • Did not address cellulitis prevention, which is a major ongoing concern for lymphedema patients

Claude 3.5

  • Could have discussed advanced surgical options (lymphovenous anastomosis) for patients not responding to CDT
  • Did not mention bioimpedance spectroscopy for early subclinical detection
  • Could have addressed the impact on exercise and physical activity more specifically (exercise is safe and beneficial, but many patients restrict activity out of fear)

Gemini

  • Insufficient depth for a chronic, progressive condition
  • No discussion of CDT or its components
  • Missing information about the staging and progressive nature of lymphedema
  • Did not address cellulitis risk or precautions for the affected limb

Med-PaLM 2

  • Microsurgical discussion may create unrealistic expectations — these procedures are available at limited specialized centers
  • Could have provided more practical day-to-day management advice
  • Did not adequately address the emotional impact of a new chronic condition after cancer treatment

Red Flags All Models Should Mention

For lymphedema, any AI response should identify these warning signs:

  • Sudden increase in swelling, redness, warmth, and pain (possible cellulitis — requires immediate antibiotics)
  • Fever with arm swelling (cellulitis can progress rapidly and become life-threatening)
  • New onset of swelling in a previously stable limb (possible disease recurrence — requires oncology evaluation)
  • Skin changes including hardening, thickening, or papillomatosis (suggests disease progression)
  • Open wounds or skin breakdown on the lymphedematous limb (infection risk)
  • Functional impairment affecting daily activities or work
  • Signs of deep vein thrombosis (swelling with pain, warmth, and redness that may mimic or coexist with lymphedema)

Assessment: Claude 3.5 provided the most thorough safety coverage, particularly regarding cellulitis prevention and the need to rule out disease recurrence with new swelling. Gemini’s coverage was inadequate for a condition with serious potential complications.

When to Trust AI vs. See a Doctor

AI Can Reasonably Help With:

  • Understanding what lymphedema is and why it can develop years after cancer treatment
  • Learning about CDT components and what to expect from treatment
  • Understanding daily precautions for the affected limb
  • Reducing anxiety by understanding that lymphedema is manageable with proper care

See a Doctor When:

  • You notice any new or increasing swelling in a limb after cancer treatment (seek prompt evaluation)
  • You develop redness, warmth, or fever in the affected limb (possible cellulitis — urgent)
  • You need a referral to a certified lymphedema therapist
  • Lymphedema is progressing despite management
  • You want to discuss advanced treatment options
  • You need compression garment fitting or replacement

Can AI Replace Your Doctor? What the Research Says explains why lymphedema requires hands-on assessment and individualized treatment by trained specialists.

Methodology

We submitted the identical patient scenario to GPT-4, Claude 3.5 Sonnet, Gemini, and Med-PaLM 2 under default settings. Responses were evaluated by our editorial team against current ISL and National Lymphedema Network guidelines. Scores reflect accuracy, empathy, practical management guidance, and safety communication. Model outputs are not reproduced verbatim to avoid misuse.

Key Takeaways

  • All models correctly identified the presentation as breast cancer-related lymphedema, but only Claude and Med-PaLM 2 addressed the critical point that early treatment produces significantly better outcomes
  • Claude 3.5 scored highest for providing comprehensive, practical management guidance including CDT components, cellulitis prevention, and compression garment use
  • Lymphedema cannot be cured, but with consistent management through CDT, most patients maintain good limb function and prevent progression
  • Cellulitis is a common and potentially serious complication affecting approximately ~20-40% of lymphedema patients, and prevention strategies should be a central part of any AI response
  • Cancer survivors should be vigilant for lymphedema symptoms indefinitely, as onset can occur years to decades after treatment

Next Steps

Published on mdtalks.com | Editorial Team | Last updated: 2026-03-12

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.